sponsored
PatientsVille.com Logo

PatientsVille

Ranitidine and Dilaudid

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectRanitidineDilaudid
DEATH0.9% 15.9%
TOXICITY TO VARIOUS AGENTS0% 12.2%
OVERDOSE0% 7.8%
NAUSEA3.4% 2.6%
DYSPNOEA3% 1.3%
PAIN2.1% 2.9%
DRUG INEFFECTIVE2.7% 1.8%
FATIGUE2.7% 1.7%
DIARRHOEA2.7% 1.4%
VOMITING2.5% 1.8%
HEADACHE2.5% 1.2%
DIZZINESS2.2% 1%
DRUG ABUSE0% 2.1%
MALAISE1.9% 0.9%
ASTHENIA1.7% 1%
PYREXIA1.7% 0.9%
PNEUMONIA1.5% 1%
ARTHRALGIA1.5% 0.9%
DRUG DEPENDENCE0% 1.5%
ABDOMINAL PAIN1.4% 1.1%
FALL1.4% 1%
OFF LABEL USE1.4% 0.8%
DRUG HYPERSENSITIVITY0.6% 1.4%
RASH1.4% 0.6%
PRURITUS1.4% 0.5%
PAIN IN EXTREMITY1.3% 0.8%
CHEST PAIN1.3% 0.6%
HYPOTENSION1.3% 0.6%
COUGH1.3% 0.4%
BACK PAIN1.2% 1%
ANXIETY1.2% 0.9%
WEIGHT DECREASED1.2% 0.8%
INSOMNIA1.2% 0.7%
ACUTE KIDNEY INJURY1.2% 0%
CONSTIPATION1.1% 0.8%
ANAEMIA1.1% 0.6%
DEPRESSION1.1% 0.6%
HYPERTENSION1.1% 0.5%
ABDOMINAL PAIN UPPER1.1% 0.4%
CHRONIC KIDNEY DISEASE1.1% 0%
DRUG WITHDRAWAL SYNDROME NEONATAL0% 1.1%
DECREASED APPETITE1% 0.6%
CONFUSIONAL STATE1% 0.6%
CONDITION AGGRAVATED1% 0.5%
RENAL FAILURE1% 0.3%
URINARY TRACT INFECTION0.9% 0.5%
ERYTHEMA0.9% 0.3%
DRUG INTERACTION0.9% 0%
ACCIDENTAL OVERDOSE0% 0.9%
DEHYDRATION0.8% 0.7%
SOMNOLENCE0.8% 0.7%
MUSCLE SPASMS0.8% 0.5%
FEELING ABNORMAL0.8% 0.5%
TREMOR0.8% 0.4%
DRUG WITHDRAWAL SYNDROME0% 0.8%
URTICARIA0.8% 0%
HYPERSENSITIVITY0.8% 0%
GASTROOESOPHAGEAL REFLUX DISEASE0.8% 0%
GAIT DISTURBANCE0.7% 0.6%
HYPOAESTHESIA0.7% 0.6%
SEPSIS0.7% 0.5%
HYPERHIDROSIS0.7% 0.5%
OEDEMA PERIPHERAL0.7% 0.5%
LOSS OF CONSCIOUSNESS0.7% 0.4%
PARAESTHESIA0.7% 0.4%
WEIGHT INCREASED0.7% 0.4%
HAEMOGLOBIN DECREASED0.7% 0.4%
BLOOD PRESSURE INCREASED0.7% 0.3%
TACHYCARDIA0.7% 0.3%
MYALGIA0.7% 0.3%
DRUG DOSE OMISSION0.7% 0.3%
DYSPEPSIA0.7% 0%
CHEST DISCOMFORT0.7% 0%
MYOCARDIAL INFARCTION0.7% 0%
FLUSHING0.7% 0%
PULMONARY EMBOLISM0.5% 0.6%
VISION BLURRED0.6% 0.3%
THROMBOCYTOPENIA0.6% 0.3%
ABDOMINAL DISCOMFORT0.6% 0.3%
NEUTROPENIA0.6% 0%
ALOPECIA0.6% 0%
ANAPHYLACTIC REACTION0.6% 0%
NASOPHARYNGITIS0.6% 0%
CHILLS0.5% 0.4%
PERIPHERAL SWELLING0.5% 0.4%
CONTUSION0.5% 0.3%
HEART RATE INCREASED0.5% 0.3%
ABDOMINAL DISTENSION0.5% 0.3%
MEMORY IMPAIRMENT0.5% 0.3%
DYSPHAGIA0.5% 0.3%
RESPIRATORY FAILURE0.5% 0.3%
MUSCULAR WEAKNESS0.5% 0.3%
INTENTIONAL PRODUCT MISUSE0% 0.5%
INJURY0% 0.5%
INFECTION0% 0.5%
INJECTION SITE PAIN0.5% 0%
ASTHMA0.5% 0%
BLOOD CREATININE INCREASED0.5% 0%
HYPONATRAEMIA0.5% 0%
PRODUCT QUALITY ISSUE0.5% 0%
RENAL FAILURE ACUTE0.5% 0%
PLATELET COUNT DECREASED0.5% 0%
PALPITATIONS0.5% 0%
SYNCOPE0.5% 0%
CARDIAC ARREST0.5% 0%
ATRIAL FIBRILLATION0.5% 0%
BLOOD GLUCOSE INCREASED0.5% 0%
GASTROINTESTINAL HAEMORRHAGE0.5% 0%
CEREBROVASCULAR ACCIDENT0.5% 0%
BRADYCARDIA0.5% 0%
RHEUMATOID ARTHRITIS0% 0.4%
MALIGNANT NEOPLASM PROGRESSION0% 0.4%
DISEASE PROGRESSION0% 0.4%
DEEP VEIN THROMBOSIS0% 0.4%
HERPES ZOSTER0% 0.3%
NEUROPATHY PERIPHERAL0% 0.3%
LETHARGY0% 0.3%
UNRESPONSIVE TO STIMULI0% 0.3%
CELLULITIS0% 0.3%
SUBSTANCE ABUSE0% 0.3%
ARTHRITIS0% 0.3%
MIGRAINE0% 0.3%
HALLUCINATION0% 0.3%
MENTAL STATUS CHANGES0% 0.3%
EMOTIONAL DISTRESS0% 0.3%
PLEURAL EFFUSION0% 0.3%
GENERAL PHYSICAL HEALTH DETERIORATION0% 0.3%
JOINT SWELLING0% 0.3%
SWELLING0% 0.3%

New treatments are found every day. View current Ranitidine research studies and Dilaudid clinical trials

1